Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
An oral disease, general anti-inflammatory technology, applied in oral care, drug combination, respiratory system diseases, etc., to achieve immunity without side effects, improve immunity, analgesic effect and non-toxic effect
Inactive Publication Date: 2009-05-13
王莉
View PDF0 Cites 11 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Toxicology research experiments have proved that in acute toxicity experiments, we increased the dosage to the most concentrated level (400 times that of human consum
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0011] The present invention covers various formulations with the same ratio, which are used to treat diseases of the oral system. The main active ingredient used is alpha-mangostin (alpha-mangostin), and its content ranges from 1.2% to 99.8% of the dose. With appropriate fillers, the content of mangostin is 2 mg to 10 g. The product can be Made into tablets, capsules, pills, powders, sprays, injections or other dosage forms of 2 mg to 10 g for administration, injection or external use, and the daily oral or other dosage of the finished product should not be less than 1.2 mg. The product of the invention has anti-inflammation, rapid analgesic effect, non-toxicity, no side effect and new product with the effect of improving immunity. The diseases mainly treated include: mouth ulcers, pharyngitis, tonsillitis, periodontitis, gingivitis, herpes, mumps, pharyngitis, acinar atrophy of minor salivary glands and mixed salivary gland tumors, gingival tumors, hemangiomas, lymphatic ves...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a novel broad-spectrum anti-inflammation analgesic drug for curing various oral diseases. The invention discloses a main compound extracted from mangosteen:Garcinia mangostana, i.e. mangostin, the mangostin is taken as the maim active component and combined with the commonly-used filling agents in various pharmaceutical industries to be prepared into various dosage forms or as drugs, health care products, food additives and the like, and the mangostin can be internally and externally used for ulcerative stomatitis, pharyngitis and the like, and also can be used for preening and curing the oral diseases, for example, the benign and malignant tumors of oral cavity. The content of the mangostin is between 1.2 and 99.8 percent, can be separately used or used by matching other substances, and also can be used for preventing and curing the oral diseases of animals. The product overcomes the defects in the prior drug for curing the oral diseases, such as poor effect, irritability, high recurrence rate, side-effect and the like, and is the efficient and broad-spectrum new drug with anti-inflammation, rapid abirritation, non-toxicity, no side-effect and enhanced immunity.
Description
Technical field: [0001] Oral diseases such as oral inflammation and benign and malignant tumors of the oral and maxillofacial area are common and frequently occurring diseases, including: oral ulcers, chronic pharyngitis, tonsillitis and other oral diseases (including upper respiratory tract infection), salivary gland Mixed tumor, gingival tumor, hemangioma, lymphangioma, neurofibroma, fibroma, giant cell tumor, osteoma, odontoma, ameloblastoma, squamous cell carcinoma, etc. The pathogenesis of oral diseases is relatively complex, and is usually closely related to trauma, heredity, overwork, mental factors, lack of certain vitamins and trace elements, immune diseases and other diseases, usually manifested as congestion, edema, itching or pain, ulceration , bleeding, swollen lymph nodes, herpes, salivation, difficulty chewing, bad breath, cancer and other symptoms. At present, medicine adopts traditional treatment methods such as antibiotics, hormone drugs, chemoradiotherapy, ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.